Pharmaceuticals in the United States

Pharmaceuticals in the United States

Code: ML-OHME4727 | Published: Dec-2015 | Pages: 41 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United States pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2014 annual average exchange rates.

- The US pharmaceuticals market had total revenues of $303.9bn in 2014, representing a compound annual growth rate (CAGR) of 3.8% between 2010 and 2014.

- The USA is the worlds largest market and maintains good growth consistently despite its already highly developed nature due to the very strong private health sector.

- The performance of the market is forecast to accelerate, with an anticipated CAGR of 5.2% for the five-year period 2014 - 2019, which is expected to drive the market to a value of $390.7bn by the end of 2019.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in the United States

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States

Leading company profiles reveal details of key pharmaceuticals market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the United States economy

Reasons To Buy
What was the size of the United States pharmaceuticals market by value in 2014?

What will be the size of the United States pharmaceuticals market in 2019?

What factors are affecting the strength of competition in the United States pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in the United Statess pharmaceuticals market?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Geography segmentation 9
Market share 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 14
Supplier power 16
New entrants 17
Threat of substitutes 19
Degree of rivalry 20
Leading Companies 22
GlaxoSmithKline Plc 22
Johnson and Johnson 25
Merck and Co., Inc. 29
Pfizer Inc. 32
Macroeconomic Indicators 36
Country Data 36
Methodology 38
Industry associations 39
Related MarketLine research 39
Appendix 40
About MarketLine 40

List of Tables
Table 1: United States pharmaceuticals market value: $ billion, 2010-14
Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2014
Table 3: United States pharmaceuticals market share: % share, by value, 2014
Table 4: United States pharmaceuticals market value forecast: $ billion, 2014-19
Table 5: GlaxoSmithKline Plc: key facts
Table 6: GlaxoSmithKline Plc: key financials ($)
Table 7: GlaxoSmithKline Plc: key financials (Pound)
Table 8: GlaxoSmithKline Plc: key financial ratios
Table 9: Johnson and Johnson: key facts
Table 10: Johnson and Johnson: key financials ($)
Table 11: Johnson and Johnson: key financial ratios
Table 12: Merck and Co., Inc.: key facts
Table 13: Merck and Co., Inc.: key financials ($)
Table 14: Merck and Co., Inc.: key financial ratios
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: key financials ($)
Table 17: Pfizer Inc.: key financial ratios
Table 18: United States size of population (million), 2010-14
Table 19: United States gdp (constant 2005 prices, $ billion), 2010-14
Table 20: United States gdp (current prices, $ billion), 2010-14
Table 21: United States inflation, 2010-14
Table 22: United States consumer price index (absolute), 2010-14
Table 23: United States exchange rate, 2010-14

List of Figures
Figure 1: United States pharmaceuticals market value: $ billion, 2010-14
Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2014
Figure 3: United States pharmaceuticals market share: % share, by value, 2014
Figure 4: United States pharmaceuticals market value forecast: $ billion, 2014-19
Figure 5: Forces driving competition in the pharmaceuticals market in the United States, 2014
Figure 6: Drivers of buyer power in the pharmaceuticals market in the United States, 2014
Figure 7: Drivers of supplier power in the pharmaceuticals market in the United States, 2014
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2014
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2014
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2014
Figure 11: GlaxoSmithKline Plc: revenues and profitability
Figure 12: GlaxoSmithKline Plc: assets and liabilities
Figure 13: Johnson and Johnson: revenues and profitability
Figure 14: Johnson and Johnson: assets and liabilities
Figure 15: Merck and Co., Inc.: revenues and profitability
Figure 16: Merck and Co., Inc.: assets and liabilities
Figure 17: Pfizer Inc.: revenues and profitability
Figure 18: Pfizer Inc.: assets and liabilities
GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co., Inc., Pfizer Inc.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
MarketLine